Results 171 to 180 of about 76,984 (297)

Production and Functional Verification of 8‐Gene (GGTA1, CMAH, β4GalNT2, hCD46, hCD55, hCD59, hTBM, hCD39)‐Edited Donor Pigs for Xenotransplantation

Cell Proliferation, EarlyView.
Schematic representation of generation of 8‐gene‐edited cloned pigs and their verification by pig to non‐human primate kidney xenotransplantation. ABSTRACT Gene‐edited (GE) pig‐to‐human xenotransplantation continues to make breakthroughs, but which kind of gene combination is suitable for organ‐specific transplantation remains unclear.
Jiaoxiang Wang, Kaixiang Xu, Tao Liu, Heng Zhao, Muhammad Ameen Jamal, Gen Chen, Xiaoying Huo, Chang Yang, Deling Jiao, Taiyun Wei, Hanfei Huang, Hongfang Zhao, Jianxiong Guo, Fengchong Wang, Xiong Zhang, Kai Liu, Siming Qu, Gang Wang, Hui Guo, Gang Chen, Hong‐Ye Zhao, Zhong Zeng, Kefeng Dou, Hong‐Jiang Wei   +23 more
wiley   +1 more source

Tacrolimus [PDF]

Reactions Weekly, 2021
openaire   +1 more source

Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation

, 1999
Donna Przepiorka, I. Khouri, Cindy Ippoliti, Naoto T. Ueno, Rakesh Mehra, M Körbling, Sergio Giralt, James Gajewski, Harald E. Fischer, Michèle L. Donato, Karen R. Cleary, David F. Claxton, K-W Chan, Ira Braunschweig, Koen van Besien, BS Andersson, Paolo Anderlini, R. Champlin   +17 more
openalex   +1 more source

Cardiac changes at autopsy in adult liver transplant recipients under tacrolimus [PDF]

, 1997
Ajai Khanna, Ashokkumar Jain, Galal M. Ziady, Anthony J. Demetris, John J. Fung, Dion Kramer, Thomas E. Starzl   +6 more
openalex   +1 more source

Adjustment of Surveillance Intervals for Ulcerative Colitis‐Associated Neoplasia Based on Disease Duration

Digestive Endoscopy, EarlyView.
ABSTRACT Objectives The risk of colitis‐associated cancer increases with disease duration in ulcerative colitis (UC), yet surveillance colonoscopy protocols generally stratify risk uniformly for patients with disease lasting over 8 years. This study evaluated whether shorter surveillance intervals might enhance lesion detection rates in patients with ...
Ryoya Sakakibara, Shinya Sugimoto, Yuta Kaieda, Hiroki Kiyohara, Yusuke Yoshimatsu, Kaoru Takabayashi, Soichiro Murakami, Miho Kawaida, Tomohisa Sujino, Naoki Hosoe, Motohiko Kato, Yasushi Iwao, Yohei Mikami, Takanori Kanai   +13 more
wiley   +1 more source

Pharmacogenetics association with long-term clinical evolution in a kidney transplant patients cohort. [PDF]

Curr Res Pharmacol Drug Discov
Sendra L, Olivera-Pasquini GG, Zucchet EG, Genvigir FDV, Beneyto MI, Hernández-Jaras J, Herrero MJ, Aliño SF.   +7 more
europepmc   +1 more source

Tacrolimus nephrotoxicity after renal transplantation [PDF]

, 1997
Sunita Katari, Mario Magnone, Ron Shapiro, Mark L. Jordan, Velma P. Scantlebury, Carlos Vivas, H. Albin Gritsch, J McCauley, TE Starzl, Anthony J. Demetris, Parmjeet Randhawa   +10 more
openalex   +1 more source

Branched‐chain amino acids and all‐cause mortality in patients with liver cirrhosis, and the onset of diabetes in liver transplant recipients

European Journal of Clinical Investigation, EarlyView.
Our study demonstrates that total BCAA levels increase following liver transplantation. In patients with cirrhosis, higher total BCAA levels are associated with a reduced risk of all‐cause mortality. However, while this association is not observed in liver transplant recipients, elevated total BCAA levels are strongly linked to an increased risk of new‐
Yakun Li, Mateo Chvatal‐Medina, Maria Camila Trillos‐Almanza, Margery A. Connelly, Han Moshage, Stephan J. L. Bakker, Vincent E. de Meijer, Hans Blokzijl, Robin P. F. Dullaart, TransplantLines Investigators   +9 more
wiley   +1 more source

Donor and recipient genetic variants in drug metabolizing enzymes and transporters affect early tacrolimus pharmacokinetics after liver transplantation. [PDF]

Sci Rep
Ladd AD, Angeli-Pahim I, Lewis D, Warren C, Nittu S, Lamba J, Duarte S, Zarrinpar A.   +7 more
europepmc   +1 more source

HOW BEST TO USE TACROLIMUS (FK506) FOR TREATMENT OF STEROID- AND OKT3-RESISTANT REJECTION AFTER RENAL TRANSPLANTATION

, 1996
Oliver K. Eberhard, Volker Kliem, Karl Oldhafer, Hans J. Schlitt, R. Pichlmayr, Karl M. Koch, R. Brunkhorst   +6 more
openalex   +1 more source